Paragon Care Limited
ASX: PGC
Integration progress solid, but weak momentum tempers near-term recovery expectations.
(Source: TradingView) 3-Month Performance Profile of PGC on a DTF compared to S&P/ASX 200 (XJO).
Paragon Care Limited reported a transformational FY25, driven by the acquisition of Oborne and merger with CH2, alongside the launch of its 3-2-1 strategy to integrate
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
